Dilatation of the oesophagus is a relatively high-risk intervention, and is required by an increasing range of disease states. Moreover, there is scarcity of evidence in the literature to guide clinicians on how to safely perform this procedure. These guidelines deal specifically with the dilatation procedure using balloon or bougie devices as a primary treatment strategy for non-malignant narrowing of the oesophagus. The use of stents is outside the remit of this paper; however, for cases of dilatation failure, alternative techniques—including stents—will be listed. The guideline is divided into the following subheadings: (1) patient preparation; (2) the dilatation procedure; (3) aftercare and (4) disease-specific considerations. A systematic literature search was performed. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool was used to evaluate the quality of evidence and decide on the strength of recommendations made.
FingerprintDive into the research topics of 'UK guidelines on oesophageal dilatation in clinical practice'. Together they form a unique fingerprint.
Sami, S. S. (Creator), Haboubi, H. N. (Creator), Ang, Y. (Creator), Boger, P. (Creator), Bhandari, P. (Creator), De Caestecker, J. (Creator), Griffiths, H. (Creator), Haidry, R. (Creator), Laasch, H. (Creator), Patel, P. (Creator), Paterson, S. (Creator), Ragunath, K. (Creator), Watson, P. J. (Creator), Siersema, P. D. (Creator) & Attwood, S. E. (Creator), BMJ Publishing Group, 1 Jun 2018